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The National Toxicology Program (NTP) was
established by the Department of Health and
Human Services in 1978 to coordinate toxicolog-
ical testing programs within the department,
strengthen the science base in toxicology, and
provide information about potentially toxic
chemicals to health regulatory and research agen-
cies, the scientific and medical communities, and
the public. With more than 80,000 chemicals
registered for commercial use in the United States
and an estimated 2,000 new ones introduced
annually for use in products used every day, the
NTP has its work cut out for it—prioritization is
crucial for the program to meet the challenge of
studying the compounds and chemicals of the
most concern to the most consumers. 
The NTP continuously solicits and reviews
nominations for toxicological studies to be
undertaken on substances of potential human
health concern. Nominations are accepted from
academia, federal and state regulatory and health
agencies, industry, labor unions, environmental
groups, and the general public. Substances are
generally studied for reproductive and develop-
mental toxicity, genotoxicity, immunotoxicity,
metabolism and disposition, and carcinogenicity. 
At the 24 May 2000 meeting of the pro-
gram’s Board of Scientific Counselors, partici-
pants endorsed five areas of ongoing NTP study
that are expected to receive even more attention
in coming years. Although identified as focus
areas, NTP studies are not restricted to these five
areas; instead, their “focus” status merely reflects
the growing importance and presence of the
chemical exposures involved in these areas in the
daily lives of large segments of the population.
Open communication and dialogue with
federal and state agencies, industry, stakeholders,
academia, and the public are crucial for the
success of NTP projects. NTP conferences and
workshops give researchers, regulators, policy
makers, and the public the chance to examine
issues together, exchange information, and reach
some agreement on future directions for
toxicology and risk assessment. NTP testing and
research results, program plans, and other
publications are distributed through mailings,
Federal Register announcements, an e-mail
mailing list, and the NTP home page at
http://ntp-server.niehs.nih.gov/. In addition,
online searchable access and printed copies of
NTP publications including the Report on
Carcinogens, NTP technical reports, NTP toxicity
studies, and other NTP documents are available
through the Environmental Health Information
Service at http://ehis.niehs.nih.gov/. 
Individuals or organizations who wish to
nominate chemicals for NTP study should contact
the NTP Nominations Faculty, National
Toxicology Program/NIEHS, MD B3-10, PO Box
12233, Research Triangle Park, North Carolina
27709 USA, e-mail: NTPNomin@niehs.nih.gov.
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DNA-Based
Products
Although DNA-based products
(“gene therapy”) offer great
promise in treating many different
human diseases, they pose a risk of
interacting with the host genome
or disrupting normal cellular
processes in unexpected and unpre-
dictable ways, with potentially
adverse consequences. The NTP is
collaborating with the Food and
Drug Administration (FDA) to study
the safety of DNA-based products
that will address the questions of
life-long risk presented by their use,
the potential for reproductive toxici-
ty or transmission of altered genetic
material to subsequent generations,
and the potential for DNA-based
products to cause autoimmune dis-
ease and immune dysfunction.
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Phototoxicology
Studies
A new phototoxicology research
and testing laboratory, a joint
endeavor between the NIEHS and
the FDA, has been established and
named the NTP Center for Photo-
toxicology. The laboratory will test
the health effects of drugs, cosmet-
ic ingredients, sun block additives,
tanning enhancers, skin colorants,
tattoo inks, and other agents upon
interaction with ultraviolet radia-
tion. The new center will yield valu-
able scientific data regarding the
risk of health problems resulting
from the combination of drugs or
other chemicals and sunlight [see
EHP 108:A212–A213 (2000)].
Medicinal
Herbs
There has been a huge surge in the
use of medicinal herbs in recent
years: approximately one-third of
the U.S. population is believed to
use some form of alternative medi-
cine, including herbal remedies.
However, under the 1994 Dietary
Supplement Health and Education
Act, proof of herbal products’ safe-
ty is not required prior to their
being marketed. So, even though
approximately 1,500 such products
are sold as dietary supplements or
ethnic traditional medicines, herbal
formulations are not subject to FDA
premarket toxicity testing to ensure
their safety or efficacy. The NTP is
planning and conducting research
on several medicinal herbs com-
pounds found in herbs that will
focus on reproductive toxicity, neu-
rotoxicity, immunotoxicity, and
effects associated with acute high-
dose exposures and chronic expo-
sures to lower doses [see EHP
107:A604–A605 (1999)].
Occupational
Health Exposures
The National Institute for Occu-
pational Safety and Health (NIOSH)
is planning a national survey to be
conducted in coordination with the
NTP and other federal agencies to
better characterize worker expo-
sures to chemical, physical, and bio-
logical agents. The information
gathered will be used for worker
education, to identify occupational
health research gaps, and to help
target areas where research can
most likely reduce workplace illness.
The NTP is currently coordinating an
effort between NIOSH and the
NIEHS to evaluate two specific
worker exposures: cellulose insula-
tion during installation and asphalt
fumes resulting from paving opera-
tions. Although cellulose insulation
has been nominated to the NTP for
general toxicologic evaluation, there
are currently little data regarding
actual worker practices, exposures,
and possible health effects caused
by its use. Asphalt fumes generated
during road paving have been
linked with acute irritation of both
mucous membranes and skin, but
no cancer risk has been established
to date.
Safe Drinking
Water
It is estimated that more than 200
million Americans use treated drink-
ing water, so the availability of safe
drinking water is a fundamental
public health concern. Although
chlorination of water is considered
one of the major public health
advances of the twentieth century,
chemical disinfection by-products
(DBPs) of the chlorination process
may cause their own problems, such
as cancer. To assist in the setting of
more protective water quality stan-
dards, the NTP is collaborating with
the U.S. Environmental Protection
Agency on a research program to
assess the potential risks from
human exposure to the major DBPs.
The program includes a systematic,
mechanism-based toxicologic eval-
uation of DBPs focusing on repro-
ductive toxicity, immunotoxicity,
neurotoxicity, and carcinogenicity
[see EHP 108:A64–A66 (2000)].